Plasma let-7i and miR-15a expression are associated with the effect of recombinant tissue plasminogen activator treatment in acute ischemic stroke patients
- 1 October 2017
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 158, 121-125
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81100882, 2016A030313582)
- Natural Science Foundation of Guangdong Province (81100882, 2016A030313582)
This publication has 22 references indexed in Scilit:
- Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humansBMC Neurology, 2013
- Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesisJournal of Clinical Investigation, 2013
- FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA ExpressionCell Reports, 2012
- Vascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb IschemiaJournal of Biological Chemistry, 2012
- Peroxisome Proliferator-Activated Receptor δ Regulation of miR-15a in Ischemia-Induced Cerebral Vascular Endothelial InjuryJournal of Neuroscience, 2010
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- MicroRNAsCell, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995